PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
B
|
BHP Group Ltd
DUS:BHP1
|
AU |
|
B
|
Boston Scientific Corp
XBER:BSX
|
US |
|
G
|
Gerresheimer AG
XHAM:GXI
|
DE |
|
Magna International Inc
TSX:MG
|
CA |
|
C
|
Commerzbank AG
OTC:CRZBF
|
DE |
|
C
|
COMPUTERSHARE LIMITED
F:QCH
|
AU |
|
Chocoladefabriken Lindt & Spruengli AG
F:LSPN
|
CH |
|
U
|
Umbrella Solar Investment SA
MAD:USI
|
ES |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
US |
|
Reliance Industries Ltd
BSE:500325
|
IN |
|
ALLETE Inc
NYSE:ALE
|
US |
|
M
|
McDonald's Corp
SGO:MCD
|
US |
|
PostNL NV
AEX:PNL
|
NL |
Wall St Price Targets
PTCT Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PTCT is 91.8 USD with a low forecast of 65.65 USD and a high forecast of 130.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PTCT's stock price target?
Price Target
91.8
USD
According to Wall Street analysts, the average 1-year price target for PTCT is 91.8 USD with a low forecast of 65.65 USD and a high forecast of 130.2 USD.
What is the Revenue forecast for PTC Therapeutics Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for PTC Therapeutics Inc?
Projected CAGR
-4%
The compound annual growth rate for Operating Income over the next 8 years is -4%.
What is the Net Income forecast for PTC Therapeutics Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 8 years is -3%.
